Compounds > urea

urea and s 1743

urea has been researched along with s 1743 in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's13 (86.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gatta, L; Miglioli, M; Osborn, JF; Perna, F; Ricci, C; Tampieri, A; Vaira, D; Vakil, N1
Aeed, H; Avni, Y; Boaz, M; Levine, A; Moss, SF; Niv, Y; Shabat-Sehayek, V; Shevah, O; Shirin, H1
Amitrano, M; Grossi, L; Manzoli, L; Marzio, L; Sacco, F; Spezzaferro, M1
Abbas, Z; Abid, S; Jafri, W; Khalid, A; Khan, R; Naz, S; Yakoob, J1
Chan, AK; Chan, FK; Chau, TS; Lee, KK; Lee, VW; Ling, TK; Waye, MM1
Boyanova, L; Cabrita, AM; de Carvalho, JN; Gonçalves, TM; Medeiros, JA; Pereira, AM; Pereira, MI1
Chang, CY; Chen, CC; Chen, MJ; Fang, YJ; Lee, JY; Lin, JT; Liou, JM; Sheng, WH; Wang, HP; Wu, MS1
Berning, M; Jebens, C; Knoth, H; Krasz, S; Kuhlisch, E; Laass, MW; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neumeyer, M; Schneider-Brachert, W; Stolte, M; Vieth, M; Zekorn, C1
Georgopoulos, S; Karatapanis, S; Laoudi, F; Lisgos, P; Papantoniou, N; Papastergiou, V; Spiliadi, C; Xirouchakis, E1
Almela, P; Angueira, T; Ariño, I; Barrio, J; Bermejo, F; Domínguez, JL; Domínguez-Muñoz, JE; Federico, A; Fernández, N; Fernandez-Bermejo, M; Ferrer-Barcelo, L; Gisbert, JP; Gomez, B; Gomez-Camarero, J; Gravina, AG; Lucendo, AJ; Marín, AC; Martin-Noguerol, E; Martorano, M; McNicholl, AG; Medina, E; Millastre, J; Miranda, A; Modolell, I; Molina-Infante, J; Ortuño, J; Perez-Aisa, Á; Perona, M; Rodríguez-Tellez, M; Romano, M1
Algaba, A; Angueira, T; Barrio, J; Bermejo, F; Castro-Fernández, M; Del Castillo, F; Domínguez, JL; Federico, A; Fernández-Salazar, L; Gisbert, JP; Gómez, B; Gómez, J; Gravina, AG; Herranz, M; Lucendo, AJ; Marín, AC; Martorano, M; McNicholl, AG; Miranda, A; Modolell, I; Molina-Infante, J; Ortuño, J; Pabón, M; Romano, M; Solís-Muñoz, P; Velayos, B1
Georgopoulos, SD; Grivas, E; Kasapidis, P; Laoudi, F; Martinez-Gonzales, B; Mentis, A; Michopoulos, S; Petraki, K; Sgouras, D; Sotiropoulou, M; Spiliadi, C; Xirouchakis, E; Zampeli, E; Zografos, K1
Ding, Y; Fu, W; Song, Z; Suo, B; Tian, X; Wang, L; Xue, Y; Zhou, L1
Aygen, S; Labenz, J; Malfertheiner, P; Tepeš, B1
Chen, DF; Fan, L; Lan, CH; Wang, TY; Wang, XW; Yang, J; Zhang, Y; Zhu, YJ1

Trials

13 trial(s) available for urea and s 1743

ArticleYear
Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:5

    Topics: Administration, Oral; Adult; Aged; Aluminum Hydroxide; Antacids; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Esomeprazole; Feces; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Reference Values; Single-Blind Method; Treatment Outcome; Urea

2004
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
    Alimentary pharmacology & therapeutics, 2004, Jul-01, Volume: 20, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Esomeprazole; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Urea

2004
Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:2

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Urea; Young Adult

2010
Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Breath Tests; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Middle Aged; Mutation; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Rabeprazole; Urea

2010
Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Probiotics; Single-Blind Method; Treatment Outcome; Urea; Young Adult

2011
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP2C19; DNA Gyrase; Drug Monitoring; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Urea

2011
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.
    Helicobacter, 2011, Volume: 16, Issue:6

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Salvage Therapy; Time Factors; Treatment Outcome; Urea; White People

2011
Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
    Journal of clinical gastroenterology, 2013, Volume: 47, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome; Urea

2013
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
    Alimentary pharmacology & therapeutics, 2015, Volume: 41, Issue:8

    Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Breath Tests; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Urea

2015
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
    European journal of internal medicine, 2016, Volume: 32

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Urea

2016
Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
    Digestive diseases and sciences, 2017, Volume: 62, Issue:6

    Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Cefuroxime; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Medication Adherence; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Failure; Urea

2017
Modified
    World journal of gastroenterology, 2017, Aug-28, Volume: 23, Issue:32

    Topics: Adult; Aged; Biopsy; Breath Tests; Carbon Isotopes; Dyspepsia; Esomeprazole; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Sensitivity and Specificity; Urea

2017
Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
    The American journal of gastroenterology, 2019, Volume: 114, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Costs; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Organometallic Compounds; Treatment Outcome; Urea

2019

Other Studies

2 other study(ies) available for urea and s 1743

ArticleYear
Risk factors associated with Helicobacter pylori infection treatment failure in a high prevalence area.
    Epidemiology and infection, 2011, Volume: 139, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pakistan; Point Mutation; Prevalence; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Failure; Urea; Virulence Factors; Young Adult

2011
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:2

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Failure; Treatment Outcome; Urea

2015